Medical Care
Global Vesicular Stomatitis (VS) Therapeutics Market Research Report 2025
- Sep 18, 25
- ID: 507546
- Pages: 84
- Figures: 83
- Views: 9
This report aims to provide a comprehensive presentation of the global market for Vesicular Stomatitis (VS) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vesicular Stomatitis (VS) Therapeutics.
The Vesicular Stomatitis (VS) Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vesicular Stomatitis (VS) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vesicular Stomatitis (VS) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Merck & Co
Zoetis
Vedco
Elanco
Ceva Santé Animale
Vibrac
Vetoquinol
IDEXX Laboratories
Covetrus
Neogen
Grand Pharmaceutical Group
Segment by Type
Symptomatic Medications
Vaccination
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vesicular Stomatitis (VS) Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Vesicular Stomatitis (VS) Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vesicular Stomatitis (VS) Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vesicular Stomatitis (VS) Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Merck & Co
Zoetis
Vedco
Elanco
Ceva Santé Animale
Vibrac
Vetoquinol
IDEXX Laboratories
Covetrus
Neogen
Grand Pharmaceutical Group
Segment by Type
Symptomatic Medications
Vaccination
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vesicular Stomatitis (VS) Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Symptomatic Medications
1.2.3 Vaccination
1.3 Market by Application
1.3.1 Global Vesicular Stomatitis (VS) Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Perspective (2020-2031)
2.2 Global Vesicular Stomatitis (VS) Therapeutics Growth Trends by Region
2.2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Vesicular Stomatitis (VS) Therapeutics Market Dynamics
2.3.1 Vesicular Stomatitis (VS) Therapeutics Industry Trends
2.3.2 Vesicular Stomatitis (VS) Therapeutics Market Drivers
2.3.3 Vesicular Stomatitis (VS) Therapeutics Market Challenges
2.3.4 Vesicular Stomatitis (VS) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vesicular Stomatitis (VS) Therapeutics Players by Revenue
3.1.1 Global Top Vesicular Stomatitis (VS) Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vesicular Stomatitis (VS) Therapeutics Revenue
3.4 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio
3.4.1 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vesicular Stomatitis (VS) Therapeutics Revenue in 2024
3.5 Global Key Players of Vesicular Stomatitis (VS) Therapeutics Head office and Area Served
3.6 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application
3.7 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Type
4.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2026-2031)
5 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Application
5.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
6.2 North America Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
6.4 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
7.4 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
9.2 Latin America Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Introduction
11.2.4 Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.2.5 Merck & Co Recent Development
11.3 Zoetis
11.3.1 Zoetis Company Details
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Introduction
11.3.4 Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.3.5 Zoetis Recent Development
11.4 Vedco
11.4.1 Vedco Company Details
11.4.2 Vedco Business Overview
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Introduction
11.4.4 Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.4.5 Vedco Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Elanco Business Overview
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Introduction
11.5.4 Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.5.5 Elanco Recent Development
11.6 Ceva Santé Animale
11.6.1 Ceva Santé Animale Company Details
11.6.2 Ceva Santé Animale Business Overview
11.6.3 Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Introduction
11.6.4 Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.6.5 Ceva Santé Animale Recent Development
11.7 Vibrac
11.7.1 Vibrac Company Details
11.7.2 Vibrac Business Overview
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Introduction
11.7.4 Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.7.5 Vibrac Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Details
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Introduction
11.8.4 Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.8.5 Vetoquinol Recent Development
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Details
11.9.2 IDEXX Laboratories Business Overview
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Introduction
11.9.4 IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.9.5 IDEXX Laboratories Recent Development
11.10 Covetrus
11.10.1 Covetrus Company Details
11.10.2 Covetrus Business Overview
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Introduction
11.10.4 Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.10.5 Covetrus Recent Development
11.11 Neogen
11.11.1 Neogen Company Details
11.11.2 Neogen Business Overview
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Introduction
11.11.4 Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.11.5 Neogen Recent Development
11.12 Grand Pharmaceutical Group
11.12.1 Grand Pharmaceutical Group Company Details
11.12.2 Grand Pharmaceutical Group Business Overview
11.12.3 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Introduction
11.12.4 Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.12.5 Grand Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Symptomatic Medications
1.2.3 Vaccination
1.3 Market by Application
1.3.1 Global Vesicular Stomatitis (VS) Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Perspective (2020-2031)
2.2 Global Vesicular Stomatitis (VS) Therapeutics Growth Trends by Region
2.2.1 Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Vesicular Stomatitis (VS) Therapeutics Market Dynamics
2.3.1 Vesicular Stomatitis (VS) Therapeutics Industry Trends
2.3.2 Vesicular Stomatitis (VS) Therapeutics Market Drivers
2.3.3 Vesicular Stomatitis (VS) Therapeutics Market Challenges
2.3.4 Vesicular Stomatitis (VS) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vesicular Stomatitis (VS) Therapeutics Players by Revenue
3.1.1 Global Top Vesicular Stomatitis (VS) Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Vesicular Stomatitis (VS) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vesicular Stomatitis (VS) Therapeutics Revenue
3.4 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio
3.4.1 Global Vesicular Stomatitis (VS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vesicular Stomatitis (VS) Therapeutics Revenue in 2024
3.5 Global Key Players of Vesicular Stomatitis (VS) Therapeutics Head office and Area Served
3.6 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application
3.7 Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Type
4.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2026-2031)
5 Vesicular Stomatitis (VS) Therapeutics Breakdown Data by Application
5.1 Global Vesicular Stomatitis (VS) Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
6.2 North America Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
6.4 North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
7.2 Europe Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
7.4 Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
9.2 Latin America Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Vesicular Stomatitis (VS) Therapeutics Introduction
11.2.4 Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.2.5 Merck & Co Recent Development
11.3 Zoetis
11.3.1 Zoetis Company Details
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Vesicular Stomatitis (VS) Therapeutics Introduction
11.3.4 Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.3.5 Zoetis Recent Development
11.4 Vedco
11.4.1 Vedco Company Details
11.4.2 Vedco Business Overview
11.4.3 Vedco Vesicular Stomatitis (VS) Therapeutics Introduction
11.4.4 Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.4.5 Vedco Recent Development
11.5 Elanco
11.5.1 Elanco Company Details
11.5.2 Elanco Business Overview
11.5.3 Elanco Vesicular Stomatitis (VS) Therapeutics Introduction
11.5.4 Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.5.5 Elanco Recent Development
11.6 Ceva Santé Animale
11.6.1 Ceva Santé Animale Company Details
11.6.2 Ceva Santé Animale Business Overview
11.6.3 Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Introduction
11.6.4 Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.6.5 Ceva Santé Animale Recent Development
11.7 Vibrac
11.7.1 Vibrac Company Details
11.7.2 Vibrac Business Overview
11.7.3 Vibrac Vesicular Stomatitis (VS) Therapeutics Introduction
11.7.4 Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.7.5 Vibrac Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Details
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Vesicular Stomatitis (VS) Therapeutics Introduction
11.8.4 Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.8.5 Vetoquinol Recent Development
11.9 IDEXX Laboratories
11.9.1 IDEXX Laboratories Company Details
11.9.2 IDEXX Laboratories Business Overview
11.9.3 IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Introduction
11.9.4 IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.9.5 IDEXX Laboratories Recent Development
11.10 Covetrus
11.10.1 Covetrus Company Details
11.10.2 Covetrus Business Overview
11.10.3 Covetrus Vesicular Stomatitis (VS) Therapeutics Introduction
11.10.4 Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.10.5 Covetrus Recent Development
11.11 Neogen
11.11.1 Neogen Company Details
11.11.2 Neogen Business Overview
11.11.3 Neogen Vesicular Stomatitis (VS) Therapeutics Introduction
11.11.4 Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.11.5 Neogen Recent Development
11.12 Grand Pharmaceutical Group
11.12.1 Grand Pharmaceutical Group Company Details
11.12.2 Grand Pharmaceutical Group Business Overview
11.12.3 Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Introduction
11.12.4 Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
11.12.5 Grand Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Symptomatic Medications
Table 3. Key Players of Vaccination
Table 4. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2020-2025)
Table 8. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2026-2031)
Table 10. Vesicular Stomatitis (VS) Therapeutics Market Trends
Table 11. Vesicular Stomatitis (VS) Therapeutics Market Drivers
Table 12. Vesicular Stomatitis (VS) Therapeutics Market Challenges
Table 13. Vesicular Stomatitis (VS) Therapeutics Market Restraints
Table 14. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2024)
Table 17. Ranking of Global Top Vesicular Stomatitis (VS) Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application
Table 21. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Boehringer Ingelheim Company Details
Table 47. Boehringer Ingelheim Business Overview
Table 48. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product
Table 49. Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Boehringer Ingelheim Recent Development
Table 51. Merck & Co Company Details
Table 52. Merck & Co Business Overview
Table 53. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product
Table 54. Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Merck & Co Recent Development
Table 56. Zoetis Company Details
Table 57. Zoetis Business Overview
Table 58. Zoetis Vesicular Stomatitis (VS) Therapeutics Product
Table 59. Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Zoetis Recent Development
Table 61. Vedco Company Details
Table 62. Vedco Business Overview
Table 63. Vedco Vesicular Stomatitis (VS) Therapeutics Product
Table 64. Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Vedco Recent Development
Table 66. Elanco Company Details
Table 67. Elanco Business Overview
Table 68. Elanco Vesicular Stomatitis (VS) Therapeutics Product
Table 69. Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Elanco Recent Development
Table 71. Ceva Santé Animale Company Details
Table 72. Ceva Santé Animale Business Overview
Table 73. Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Product
Table 74. Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Ceva Santé Animale Recent Development
Table 76. Vibrac Company Details
Table 77. Vibrac Business Overview
Table 78. Vibrac Vesicular Stomatitis (VS) Therapeutics Product
Table 79. Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Vibrac Recent Development
Table 81. Vetoquinol Company Details
Table 82. Vetoquinol Business Overview
Table 83. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product
Table 84. Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Vetoquinol Recent Development
Table 86. IDEXX Laboratories Company Details
Table 87. IDEXX Laboratories Business Overview
Table 88. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product
Table 89. IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 90. IDEXX Laboratories Recent Development
Table 91. Covetrus Company Details
Table 92. Covetrus Business Overview
Table 93. Covetrus Vesicular Stomatitis (VS) Therapeutics Product
Table 94. Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Covetrus Recent Development
Table 96. Neogen Company Details
Table 97. Neogen Business Overview
Table 98. Neogen Vesicular Stomatitis (VS) Therapeutics Product
Table 99. Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Neogen Recent Development
Table 101. Grand Pharmaceutical Group Company Details
Table 102. Grand Pharmaceutical Group Business Overview
Table 103. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product
Table 104. Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Grand Pharmaceutical Group Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Vesicular Stomatitis (VS) Therapeutics Picture
Figure 2. Global Vesicular Stomatitis (VS) Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Symptomatic Medications Features
Figure 5. Vaccination Features
Figure 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Veterinary Hospitals Case Studies
Figure 9. Veterinary Clinics Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 12. Global Vesicular Stomatitis (VS) Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players in 2024
Figure 16. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue in 2024
Figure 18. North America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2020-2031)
Figure 32. China Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 48. Merck & Co Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 49. Zoetis Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 50. Vedco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 51. Elanco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 52. Ceva Santé Animale Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 53. Vibrac Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 54. Vetoquinol Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 55. IDEXX Laboratories Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 56. Covetrus Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 57. Neogen Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 58. Grand Pharmaceutical Group Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Symptomatic Medications
Table 3. Key Players of Vaccination
Table 4. Global Vesicular Stomatitis (VS) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2020-2025)
Table 8. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2026-2031)
Table 10. Vesicular Stomatitis (VS) Therapeutics Market Trends
Table 11. Vesicular Stomatitis (VS) Therapeutics Market Drivers
Table 12. Vesicular Stomatitis (VS) Therapeutics Market Challenges
Table 13. Vesicular Stomatitis (VS) Therapeutics Market Restraints
Table 14. Global Vesicular Stomatitis (VS) Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2024)
Table 17. Ranking of Global Top Vesicular Stomatitis (VS) Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Product and Application
Table 21. Global Key Players of Vesicular Stomatitis (VS) Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Vesicular Stomatitis (VS) Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Vesicular Stomatitis (VS) Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Boehringer Ingelheim Company Details
Table 47. Boehringer Ingelheim Business Overview
Table 48. Boehringer Ingelheim Vesicular Stomatitis (VS) Therapeutics Product
Table 49. Boehringer Ingelheim Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Boehringer Ingelheim Recent Development
Table 51. Merck & Co Company Details
Table 52. Merck & Co Business Overview
Table 53. Merck & Co Vesicular Stomatitis (VS) Therapeutics Product
Table 54. Merck & Co Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Merck & Co Recent Development
Table 56. Zoetis Company Details
Table 57. Zoetis Business Overview
Table 58. Zoetis Vesicular Stomatitis (VS) Therapeutics Product
Table 59. Zoetis Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Zoetis Recent Development
Table 61. Vedco Company Details
Table 62. Vedco Business Overview
Table 63. Vedco Vesicular Stomatitis (VS) Therapeutics Product
Table 64. Vedco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Vedco Recent Development
Table 66. Elanco Company Details
Table 67. Elanco Business Overview
Table 68. Elanco Vesicular Stomatitis (VS) Therapeutics Product
Table 69. Elanco Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Elanco Recent Development
Table 71. Ceva Santé Animale Company Details
Table 72. Ceva Santé Animale Business Overview
Table 73. Ceva Santé Animale Vesicular Stomatitis (VS) Therapeutics Product
Table 74. Ceva Santé Animale Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Ceva Santé Animale Recent Development
Table 76. Vibrac Company Details
Table 77. Vibrac Business Overview
Table 78. Vibrac Vesicular Stomatitis (VS) Therapeutics Product
Table 79. Vibrac Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Vibrac Recent Development
Table 81. Vetoquinol Company Details
Table 82. Vetoquinol Business Overview
Table 83. Vetoquinol Vesicular Stomatitis (VS) Therapeutics Product
Table 84. Vetoquinol Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Vetoquinol Recent Development
Table 86. IDEXX Laboratories Company Details
Table 87. IDEXX Laboratories Business Overview
Table 88. IDEXX Laboratories Vesicular Stomatitis (VS) Therapeutics Product
Table 89. IDEXX Laboratories Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 90. IDEXX Laboratories Recent Development
Table 91. Covetrus Company Details
Table 92. Covetrus Business Overview
Table 93. Covetrus Vesicular Stomatitis (VS) Therapeutics Product
Table 94. Covetrus Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Covetrus Recent Development
Table 96. Neogen Company Details
Table 97. Neogen Business Overview
Table 98. Neogen Vesicular Stomatitis (VS) Therapeutics Product
Table 99. Neogen Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Neogen Recent Development
Table 101. Grand Pharmaceutical Group Company Details
Table 102. Grand Pharmaceutical Group Business Overview
Table 103. Grand Pharmaceutical Group Vesicular Stomatitis (VS) Therapeutics Product
Table 104. Grand Pharmaceutical Group Revenue in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Grand Pharmaceutical Group Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Vesicular Stomatitis (VS) Therapeutics Picture
Figure 2. Global Vesicular Stomatitis (VS) Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Symptomatic Medications Features
Figure 5. Vaccination Features
Figure 6. Global Vesicular Stomatitis (VS) Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Veterinary Hospitals Case Studies
Figure 9. Veterinary Clinics Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Vesicular Stomatitis (VS) Therapeutics Report Years Considered
Figure 12. Global Vesicular Stomatitis (VS) Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Vesicular Stomatitis (VS) Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Vesicular Stomatitis (VS) Therapeutics Market Share by Players in 2024
Figure 16. Global Top Vesicular Stomatitis (VS) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vesicular Stomatitis (VS) Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Vesicular Stomatitis (VS) Therapeutics Revenue in 2024
Figure 18. North America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Vesicular Stomatitis (VS) Therapeutics Market Share by Region (2020-2031)
Figure 32. China Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Vesicular Stomatitis (VS) Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Vesicular Stomatitis (VS) Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 48. Merck & Co Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 49. Zoetis Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 50. Vedco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 51. Elanco Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 52. Ceva Santé Animale Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 53. Vibrac Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 54. Vetoquinol Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 55. IDEXX Laboratories Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 56. Covetrus Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 57. Neogen Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 58. Grand Pharmaceutical Group Revenue Growth Rate in Vesicular Stomatitis (VS) Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232